Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 29, 2026
Why Is Lennox International (LII) Stock Down -15.87% Today?

Why Is Lennox International (LII) Stock Down -15.87% Today?

Key Takeaways

  • Lennox International shares plunged 15.87% in intraday trading Wednesday, falling to $457.76 from a prior close of $544.11.
  • The primary catalyst was the company's Q2 2026 earnings report, which featured a slight revenue miss and a downward revision to full-year EPS guidance.
  • Residential market softness weighed heavily on the company's Home Comfort Solutions segment, where revenue declined 7% year-over-year and segment profit fell 12%.
  • Full-year EPS guidance was trimmed to a range of $23.00–$24.00, down from the prior $23.50–$25.00, with the midpoint falling roughly 4.7% below analyst consensus.
  • Building Climate Solutions showed strength with 24% revenue growth, but it was not enough to offset investor concerns about residential headwinds and margin pressures.
  • Traders are now watching for signs of stabilization in residential HVAC demand, tariff developments, and progress on acquisition integrations in the quarters ahead.

Opening Summary

Shares of LII, Lennox International Inc.—a Texas-based global leader in energy-efficient heating, ventilation, air conditioning, and refrigeration (HVACR) solutions—tumbled 15.87% during Wednesday's trading session. The stock dropped to $457.76 intraday from Tuesday's closing price of $544.11, erasing billions in market capitalization. The selloff was triggered by the company's second-quarter 2026 earnings report, released before the market opened, which revealed a modest revenue shortfall relative to Wall Street expectations and, more critically, a reduction in the company's full-year profit forecast. The results underscored persistent headwinds in the residential HVAC market that overshadowed robust performance in Lennox's commercial building segment.

Q2 Earnings: Revenue Misses, Guidance Disappoints

Lennox reported second-quarter revenue of $1.55 billion, up 3% year-over-year but narrowly below the $1.56 billion consensus estimate. GAAP diluted earnings per share came in at $7.72, essentially flat compared to $7.71 a year earlier and in line with analyst projections. While the top-line miss was modest, the real shock came from updated forward guidance. The company revised its full-year 2026 GAAP EPS outlook to a range of $23.00 to $24.00, down from the prior range of $23.50 to $25.00. At the midpoint of $23.50, the new guidance sat approximately 4.7% below the Street's consensus, signaling that management expects macro headwinds to persist longer than previously anticipated.

Operating income rose 2% to $355 million, but the total segment margin contracted 30 basis points to 23.0%. Net income slipped to $269 million from $274 million in the prior-year quarter. On a positive note, operating cash flow improved significantly to $172 million from $87 million a year ago, driven by reduced inventory levels, and the company repurchased $132 million in shares during the quarter.

Residential Weakness Offsets Commercial Strength

The two-speed nature of Lennox's business was on full display in the Q2 results. The Home Comfort Solutions segment—which serves the residential market—saw revenue decline 7% year-over-year to $936 million, with segment profit dropping 12% to $222 million. Segment margin contracted 130 basis points to 23.7%, pressured by lower sales volumes and factory under-absorption. Management pointed to challenging residential market conditions, with new construction activity remaining a "meaningful headwind." While demand improved sequentially from the first quarter and pricing actions largely offset inflationary and tariff pressures, the segment's profit headwinds from lower volumes totaled $49 million.

In stark contrast, the Building Climate Solutions segment delivered standout results, with revenue surging 24% to $610 million and segment profit jumping 29% to $155 million. Organic revenue growth of 15% was fueled by strong execution with national account customers, healthy emergency replacement activity, and expanding service offerings. Acquisitions contributed an additional 9% to revenue growth. Despite this strength, the market's laser focus on the much larger residential segment's struggles drowned out the commercial unit's success.

Guidance Cut and Tariff Uncertainty

The downward revision to full-year EPS guidance signals that Lennox's management expects cost inflation, factory under-absorption, and residential demand softness to linger through the second half of 2026. While the company reaffirmed its revenue growth target of approximately 8% (including a 5% benefit from completed acquisitions), the profit outlook downgrade suggests margin recovery will take longer than previously modeled. Tariff dynamics also injected uncertainty: while Lennox benefited from $30 million in earlier-than-expected tariff refunds during the quarter, ongoing tariff policy unpredictability and related pricing actions remain a key variable for the company's cost structure going forward.

Market Context and Trading Activity

Wednesday's selloff was accompanied by exceptionally heavy trading volume. The prior session on Tuesday had already seen roughly 1.0 million shares change hands—more than double the stock's 90-day average volume of approximately 434,000—as traders positioned ahead of earnings. Wednesday's intraday activity suggested even more elevated participation as institutional investors reassessed positions following the guidance cut. The magnitude of the drop far exceeded typical moves in the building products and HVAC sector, indicating a genuine repricing of risk rather than broad market sympathy. Broader industrial and building product peers showed relatively muted moves, confirming that the LII selloff was company-specific rather than sector-driven.

From a technical standpoint, the stock sliced through several key levels, including its 50-day moving average (which had been near $528) and its 200-day moving average (near $516), landing at levels not seen since the spring of 2026. The break below these widely watched technical markers likely accelerated selling pressure as stop-loss orders and algorithmic trading programs were triggered.

What Comes Next for LII

Looking ahead, Lennox's path to recovery depends on several interconnected factors. First, stabilization in the residential HVAC market—particularly an uptick in new construction activity and homeowner replacement demand—will be critical to reversing the Home Comfort Solutions segment's volume declines. Second, the pace and success of integrating recent acquisitions, including Duro Dyne, Supco, and the newly acquired Comfort-Aire and Century brands, will be closely monitored for their contribution to both revenue and margin profiles. Third, the trajectory of tariffs and input costs will directly influence the company's pricing power and cost absorption. On the positive side, Lennox's strong free cash flow generation (targeted at $750–$850 million for the full year), disciplined share repurchase program, and the momentum in Building Climate Solutions provide financial flexibility and a buffer against residential market weakness. Still, with residential softness persisting and the guidance revision fresh in investors' minds, the stock may face continued scrutiny until tangible signs of a residential demand recovery materialize.

Trending AI Robots

In volatile market conditions like those affecting Lennox today, some traders turn to automated strategies for data-driven decision-making. Tickeron's Trending AI Robots page features a curated selection of AI-powered trading bots that have demonstrated strong performance under current market conditions. With hundreds of bots covering thousands of tickers and employing strategies ranging from swing trading to long-term trend following, the platform identifies only the top performers for its Trending section. Each bot varies by strategy type, timeframe, performance metrics, and traded symbols, offering traders a diverse toolkit. Explore the Trending AI Robots page to discover which automated strategies are navigating today's market most effectively.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: LII

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


LII's Stochastic Oscillator is remaining in oversold zone for 8 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where LII's RSI Oscillator exited the oversold zone, of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LII advanced for three days, in of 332 cases, the price rose further within the following month. The odds of a continued upward trend are .

LII may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 24, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LII as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for LII turned negative on July 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 56 similar instances when the indicator turned negative. In of the 56 cases the stock turned lower in the days that followed. This puts the odds of success at .

LII moved below its 50-day moving average on July 29, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for LII crossed bearishly below the 50-day moving average on July 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LII declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for LII entered a downward trend on August 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.211) is normal, around the industry mean (5.483). P/E Ratio (18.699) is within average values for comparable stocks, (37.519). Projected Growth (PEG Ratio) (1.266) is also within normal values, averaging (1.634). Dividend Yield (0.013) settles around the average of (0.013) among similar stocks. P/S Ratio (2.782) is also within normal values, averaging (2.228).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LII’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. LII’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

Notable companies

The most notable companies in this group are Johnson Controls International plc (NYSE:JCI), Owens Corning (NYSE:OC), Alpha Pro Tech Ltd (ASE:APT).

Industry description

The industry manufactures products used in the construction of residential and commercial buildings. The process involves using materials and other products, and processing them to create finished items such as doors, windows, light fittings, floor coverings, climate control products and other building components and home improvement products. Masco Corporation, Allegion PLC and Lennox International Inc. are major manufacturers of such products.

Market Cap

The average market capitalization across the Building Products Industry is 11.17B. The market cap for tickers in the group ranges from 14.02K to 105.29B. TT holds the highest valuation in this group at 105.29B. The lowest valued company is MTWD at 14.02K.

High and low price notable news

The average weekly price growth across all stocks in the Building Products Industry was -4%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was -3%. CSTE experienced the highest price growth at 29%, while AEHL experienced the biggest fall at -94%.

Volume

The average weekly volume growth across all stocks in the Building Products Industry was -33%. For the same stocks of the Industry, the average monthly volume growth was 1% and the average quarterly volume growth was -14%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 52
Price Growth Rating: 56
SMR Rating: 70
Profit Risk Rating: 73
Seasonality Score: -30 (-100 ... +100)
View a ticker or compare two or three
LII
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of broad range of products for the heating, ventilation, air conditioning and refrigeration markets

Industry BuildingProducts

Profile
Details
Industry
Building Products
Address
2140 Lake Park Boulevard
Phone
+1 972 497-5000
Employees
12600
Web
https://www.lennox.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.